BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+18.16%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$9.8B
AUM Growth
+$9.8B
Cap. Flow
+$744M
Cap. Flow %
7.6%
Top 10 Hldgs %
73.27%
Holding
122
New
14
Increased
15
Reduced
12
Closed
1

Top Buys

1
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$297M
2
SGEN
Seagen Inc. Common Stock
SGEN
$173M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
$121M
4
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
$98.7M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
$72M

Top Sells

1
PCYC
PHARMACYCLICS INC
PCYC
$64.5M
2
XOMA icon
Xoma
XOMA
$22.1M
3
AMBI
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
$16.8M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$15.4M
5
RPRX
Repros Therapeutics Inc.
RPRX
$7.76M

Sector Composition

1 Healthcare 42.14%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
HRTX icon
26
Heron Therapeutics
HRTX
$208M
$26.2M 0.27%
2,607,784
– –
GILD icon
27
Gilead Sciences
GILD
$140B
$24.1M 0.25%
256,108
– –
CPRX icon
28
Catalyst Pharmaceutical
CPRX
$2.5B
$19.9M 0.2%
6,715,462
– –
RPRX
29
DELISTED
Repros Therapeutics Inc.
RPRX
$19.9M 0.2%
2,000,000
-778,654
-28% -$7.76M
AGIO icon
30
Agios Pharmaceuticals
AGIO
$2.36B
$18.3M 0.19%
163,393
-6,500
-4% -$728K
INSM icon
31
Insmed
INSM
$30.6B
$17.1M 0.17%
1,107,850
– –
OMER icon
32
Omeros
OMER
$283M
$16.1M 0.16%
648,101
-160,674
-20% -$3.98M
SGMO icon
33
Sangamo Therapeutics
SGMO
$165M
$14.5M 0.15%
955,332
+90,476
+10% +$1.38M
BLUE
34
DELISTED
bluebird bio
BLUE
$13.8M 0.14%
150,000
– –
NBIX icon
35
Neurocrine Biosciences
NBIX
$13.9B
$12.4M 0.13%
554,590
– –
CLVS
36
DELISTED
Clovis Oncology, Inc.
CLVS
$11.3M 0.12%
+202,630
New +$11.3M
MGNX icon
37
MacroGenics
MGNX
$121M
$10.9M 0.11%
311,891
– –
KYTH
38
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$9.93M 0.1%
286,255
-25,000
-8% -$867K
XNCR icon
39
Xencor
XNCR
$586M
$9.49M 0.1%
591,371
+49,008
+9% +$786K
ARWR icon
40
Arrowhead Research
ARWR
$3.75B
$9.08M 0.09%
1,230,802
– –
NGNE icon
41
Neurogene
NGNE
$278M
$9.08M 0.09%
1,210,350
-1,501
-0.1% -$11.3K
AERI
42
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$8.74M 0.09%
299,356
– –
PRQR icon
43
ProQR Therapeutics
PRQR
$247M
$8.67M 0.09%
400,000
– –
OSIR
44
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$8.17M 0.08%
510,606
– –
VIRX
45
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$8.16M 0.08%
+3,200,000
New +$8.16M
LJPC
46
DELISTED
La Jolla Pharmaceutical Company
LJPC
$7.78M 0.08%
421,631
– –
ABUS icon
47
Arbutus Biopharma
ABUS
$759M
$7.34M 0.07%
484,156
– –
EIGR
48
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$7.32M 0.07%
375,000
– –
NVAX icon
49
Novavax
NVAX
$1.24B
$7.26M 0.07%
1,223,362
– –
ACGN
50
DELISTED
Aceragen, Inc. Common Stock
ACGN
$7.18M 0.07%
1,628,172
+8,914
+0.6% +$39.3K
1
2
3 4 5